Table 2 Known cancer genes in the high-level copy number variation regions
From: Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma
|  | EC1 | Known cancer related genes in Region | EC2–3 | Known cancer related genes in Region |
|---|---|---|---|---|
High-level amplified events | ||||
 Cytoband | 5q35 | FGFR4/DOCK2 (9.09%) | 5q35 | FGFR4/DOCK2 (19.94%) |
5q32 | CD74/CSF1R (9.09%) | 5q31 | CTNNA1/NR3C1 (17.86%) | |
5q33 | PDGFRB/ZNF300 (9.09%) | 5q33 | PDGFRB/ZNF300 (17.86%) | |
High-level deletion events | ||||
 Cytoband | 9p21 | CDKN2A/CDKN2B (11.11%) | 3p25 | PPARG/RAF1/VHL (15.18%) |
9p23 | PTPRD (7.07%) | 3p21 | PBRM1/SETD2/BAP1 (15.18%) | |
3p25 | PPARG/RAF1/VHL (6.06%) | 3p22 | TGFBR2/MYD88 (14.58%) | |